UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 137

Sortiert nach

Current management of regional lymph nodes in patients with melanoma

Journal of surgical oncology, 2019-02, Vol.119 (2), p.200-207

Bartlett, Edmund K.

2019

Link zum Volltext

Verfügbarkeit prüfen

Current management of regional lymph nodes in patients with melanoma

Journal of surgical oncology, 2019-06, Vol.119 (8), p.1186-1186

Bartlett, Edmund K.

2019

Link zum Volltext

Verfügbarkeit prüfen

Utility of a Model for Predicting the Risk of Sentinel Lymph Node Metastasis in Patients With Cutaneous Melanoma

JAMA dermatology (Chicago, Ill.), 2022-06, Vol.158 (6), p.680

2022

Link zum Volltext

Verfügbarkeit prüfen

Morbidity and mortality after total gastrectomy for gastric malignancy using the American College of Surgeons National Surgical Quality Improvement Program database

Surgery, 2014-08, Vol.156 (2), p.298-304

2014

Link zum Volltext

Verfügbarkeit prüfen

The rise in metastasectomy across cancer types over the past decade

Cancer, 2015-03, Vol.121 (5), p.747-757

2015

Link zum Volltext

Verfügbarkeit prüfen

ASO Author Reflections: Why Treatment Risk Thresholds Are Needed for Patients with Melanoma

Annals of surgical oncology, 2022-09, Vol.29 (9), p.5957-5958

2022

Link zum Volltext

Verfügbarkeit prüfen

Sentinel Lymph Node Biopsy in Cutaneous Melanoma-Where Do We Stand?

JAMA dermatology (Chicago, Ill.), 2021-10, Vol.157 (10), p.1159

2021

Link zum Volltext

Verfügbarkeit prüfen

High neutrophil‐to‐lymphocyte ratio (NLR) is associated with treatment failure and death in patients who have melanoma treated with PD‐1 inhibitor monotherapy

Cancer, 2020-01, Vol.126 (1), p.76-85

2020

Link zum Volltext

Verfügbarkeit prüfen

The emerging role of immunotherapy for the treatment of sarcoma

Journal of surgical oncology, 2021-03, Vol.123 (3), p.730-738

2021

Link zum Volltext

Verfügbarkeit prüfen

ASO Visual Abstract: Does Stage Migration Occur as a Consequence of Omitting Completion Lymph Node Dissection for Melanoma?

Annals of surgical oncology, 2023-06, Vol.30 (6), p.3655-3655

2023

Link zum Volltext

Verfügbarkeit prüfen

Timing Is Everything: Could Surveillance Imaging Intensity Influence Survival in High-Risk Melanoma?

Annals of surgical oncology, 2020-10, Vol.27 (10), p.3577-3578

2020

Link zum Volltext

Verfügbarkeit prüfen

Problematic methodology in a systematic review and meta-analysis of DecisionDx-Melanoma

Journal of the American Academy of Dermatology, 2020-11, Vol.83 (5), p.e357-e358

2020

Link zum Volltext

Verfügbarkeit prüfen

Management of pelvic sarcoma

European journal of surgical oncology, 2022-11, Vol.48 (11), p.2299-2307

2022

Link zum Volltext

Verfügbarkeit prüfen

Trends in Completion Lymph Node Dissection for Patients with Melanoma

Journal of the American College of Surgeons, 2020-06, Vol.230 (6), p.1121-1122

2020

Link zum Volltext

Verfügbarkeit prüfen

Current Staging and Prognostic Factors in Melanoma

Surgical oncology clinics of North America, 2015-04, Vol.24 (2), p.215-227

2015

Link zum Volltext

Verfügbarkeit prüfen

Long-term blood pressure control in patients undergoing adrenalectomy for primary hyperaldosteronism

Surgery, 2014-12, Vol.156 (6), p.1394-1403

2014

Link zum Volltext

Verfügbarkeit prüfen

Use of a prognostic gene expression profile test for T1 cutaneous melanoma: Will it help or harm patients?

Journal of the American Academy of Dermatology, 2019-06, Vol.80 (6), p.e161-e162

2019

Link zum Volltext

Verfügbarkeit prüfen

Performance of Gene Expression Profile Tests for Prognosis in Patients With Localized Cutaneous Melanoma: A Systematic Review and Meta-analysis

JAMA dermatology (Chicago, Ill.), 2020-09, Vol.156 (9), p.953

2020

Link zum Volltext

Verfügbarkeit prüfen

Cost-Benefit Implication of Gene Expression Profiling and Adjuvant Therapy in Stage IIIA Melanoma

Journal of the American College of Surgeons, 2020-11, Vol.231 (5), p.547-554.e1

2020

Link zum Volltext

Verfügbarkeit prüfen

Morbidity and Mortality of Cytoreduction with Intraperitoneal Chemotherapy: Outcomes from the ACS NSQIP Database

Annals of surgical oncology, 2014-05, Vol.21 (5), p.1494-1500

2014

Link zum Volltext

Verfügbarkeit prüfen

Does Stage Migration Occur as a Consequence of Omitting Completion Lymph Node Dissection for Melanoma?

Annals of surgical oncology, 2023-06, Vol.30 (6), p.3648-3654

2023

Link zum Volltext

Verfügbarkeit prüfen

Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy: a review of factors contributing to morbidity and mortality

Journal of gastrointestinal oncology, 2016-02, Vol.7 (1), p.99-111

2016

Link zum Volltext

Verfügbarkeit prüfen

Are the MIA and MSKCC nomograms useful in selecting patients with melanoma for sentinel lymph node biopsy?

Journal of surgical oncology, 2023-06, Vol.127 (7), p.1167-1173

2023

Link zum Volltext

Verfügbarkeit prüfen

Sentinel Lymph Node Biopsy for T1b Melanoma: Balancing Prognostic Value and Cost

Annals of surgical oncology, 2020-12, Vol.27 (13), p.5248-5256

2020

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 137

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(125)
Mit Volltextzugriff
(109)

Publikationsform

1 weiteren anzeigen...

Weniger anzeigen...

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Current management of regional lymph nodes in patients with melanoma

Current management of regional lymph nodes in patients with melanoma

Utility of a Model for Predicting the Risk of Sentinel Lymph Node Metastasis in Patients With Cutaneous Melanoma

Morbidity and mortality after total gastrectomy for gastric malignancy using the American College of Surgeons National Surgical Quality Improvement Program database

The rise in metastasectomy across cancer types over the past decade

ASO Author Reflections: Why Treatment Risk Thresholds Are Needed for Patients with Melanoma

Sentinel Lymph Node Biopsy in Cutaneous Melanoma-Where Do We Stand?

High neutrophil‐to‐lymphocyte ratio (NLR) is associated with treatment failure and death in patients who have melanoma treated with PD‐1 inhibitor monotherapy

The emerging role of immunotherapy for the treatment of sarcoma

ASO Visual Abstract: Does Stage Migration Occur as a Consequence of Omitting Completion Lymph Node Dissection for Melanoma?

Timing Is Everything: Could Surveillance Imaging Intensity Influence Survival in High-Risk Melanoma?

Problematic methodology in a systematic review and meta-analysis of DecisionDx-Melanoma

Management of pelvic sarcoma

Trends in Completion Lymph Node Dissection for Patients with Melanoma

Current Staging and Prognostic Factors in Melanoma

Long-term blood pressure control in patients undergoing adrenalectomy for primary hyperaldosteronism

Use of a prognostic gene expression profile test for T1 cutaneous melanoma: Will it help or harm patients?

Performance of Gene Expression Profile Tests for Prognosis in Patients With Localized Cutaneous Melanoma: A Systematic Review and Meta-analysis

Cost-Benefit Implication of Gene Expression Profiling and Adjuvant Therapy in Stage IIIA Melanoma

Morbidity and Mortality of Cytoreduction with Intraperitoneal Chemotherapy: Outcomes from the ACS NSQIP Database

Does Stage Migration Occur as a Consequence of Omitting Completion Lymph Node Dissection for Melanoma?

Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy: a review of factors contributing to morbidity and mortality

Are the MIA and MSKCC nomograms useful in selecting patients with melanoma for sentinel lymph node biopsy?

Objective Response Rate Among Patients With Locally Advanced or Metastatic Sarcoma Treated With Talimogene Laherparepvec in Combination With Pembrolizumab: A Phase 2 Clinical Trial

Sentinel Lymph Node Biopsy for T1b Melanoma: Balancing Prognostic Value and Cost

Suchergebnisse filtern